Targeted therapies have revolutionized the treatment of non-small cell lung cancer (NSCLC), offering more personalized and effective options compared to traditional treatments like chemotherapy. These therapies work by targeting specific genetic mutations or proteins that drive cancer growth, allowing for more precise and less toxic treatment. One of the most well-known targets in NSCLC is…
Immunotherapy has transformed the treatment landscape for non-small cell lung cancer (NSCLC), offering new hope, particularly for patients with advanced disease. Unlike traditional treatments like chemotherapy, which directly target cancer cells, immunotherapy works by boosting the body’s immune system to recognize and attack cancer. Checkpoint inhibitors, a key class of immunotherapy drugs, have shown remarkable…